“I don’t see any purpose, but I think they are not independent of each other,” Rambaut said. “Because once this idea is caught, people will go through its stored samples and see what they can find.”
Similar errors have been reported in other studies in Italy before the virus was detected. A study published in August 2020 by the Department of Environment and Health in Rome found that SARS-Cove-2 RNA was detected in a sewer sample taken in Milan and Turin on December 1, 2011. These findings have raised suspicions of Johns Hopkins University postdock Alex Krits-Christoph, who specializes in bioinformatics studies of genetic data. The researchers conducted three different experiments, but only one came back positive. They also made their own primers, which were used to target specific regions of the RNA, although standard SARS-Cove-2 primers were used around the world at the time. “It strikes me as a bit weird,” he says.
On October 2, 2020, a study was submitted to the journal Tumor And the next day was adopted, “which is a very short, very hasty peer review – not even a peer review,” says Warobe. The researchers looked at the antibodies of volunteers enrolled in a lung cancer screening trial, recruited from all over the Italian region, and found that hundreds of participants made coronavirus antibodies by September 2019. The first official Covid-1 cases in Lombardy were publicized in Italy before the diagnosis, even long before the first official report from the Chinese authorities, shed new light on the onset and spread of the Covid-1 pandemic epidemic, “the author wrote in an interview. Can detect contagious “strains that can spread without major outbreaks. The paper was heavily covered by the English-speaking media. Do not take the necessary steps to prevent the detection of other coronavirus antibodies, such as the common cord. Marion Kupmans, a virologist at Erasmus Medical Center, who was part of the WHO team that traveled to Uhan to investigate the onset of the coronavirus epidemic, said. The study was declared under investigation by the journal in March 2021, but no corrections were made. The WHO requested that the samples be re-tested in other labs. The investigation found that none of the samples contained enough antibodies to be considered evidence of infection.
Another study found that a skin biopsy of a 25-year-old woman living in Milan was taken on November 10, when she arrived at the hospital with a rash. A few months after the close inspection, Raphael Gianotti, the chief researcher and dermatologist who treated her, found evidence of the stork-covi-2 molecule in her skin sample. The WHO wanted to investigate the case, but now no one can find the female patient, and Giannoti died in March. (The rest of the authors in the paper say there is no update on the case.)
Rambaut said the results were “used by different parties to support a particular narrative.” In particular, they have been frequently covered by China’s state media, turning to studies to show that China was not the country of origin of the virus. “Wuhan was where the coronavirus was first detected, but it wasn’t where it originated,” Zheng Guang, a former chief epidemiologist at China’s Centers for Disease Control and Prevention, told an academic conference in November 2020.